Medicare Benefits Schedule - Item 15900

BREAST, MALIGNANT TUMOUR, targeted intraoperative radiation therapy, using an Intrabeam® or Xoft® Axxent® device, delivered at the time of breast-conserving surgery (partial mastectomy or lumpectomy) for a patient who:

a) is 45 years of age or more; and

b) has a T1 or small T2 (less than or equal to 3cm in diameter) primary tumour; and

c) has an histologic Grade 1 or 2 tumour; and

d) has an oestrogen-receptor positive tumour; and

e) has a node negative malignancy; and

f) is suitable for wide local excision of a primary invasive ductal carcinoma that was diagnosed as unifocal on conventional examination and imaging; and

g) has no contra-indications to breast irradiation

Applicable only once per breast per lifetime (H)

Fee: $264.25 Benefit: 75% = $198.20

• Previous - Item 15850
• Next - Item 16003